Pretibial Myxedema
- 12/10/2002
- 0 Comments
- 13584 reads
Intravenous immunoglobulin
C. Intravenous immunoglobulin and pentoxyfylline
D. Intralesional steroids and compression bandages
Pretibial Myxedema Answer Form and Evaluation
Please complete (if submitting offline, print clearly):
Name Degree Position/Title
Organization/Institute Department
Mailing Address for Certificate (H or W):
City State Zip Code Email Address
Social Security Number Phone (area code) Fax (area code)
Answers (Refer to questions below) Click on or circle one letter for each answer:
1. A B C D
2. A B C D
3. A B C D
4. A B C D
5. A B C D
6. A B C D
Evaluation (Click on or circle one)
Excellent (4) Good (3) Satisfactory (2) Poor (1)
Accuracy and timeliness of content: 4 3 2 1
Relevance to your daily practice: 4 3 2 1
Impact on your professional effectiveness: 4 3 2 1
Relevance of the content to the learning objectives: 4 3 2 1
Effectiveness of the teaching/learning methods: 4 3 2 1
This activity avoided commercial bias or influence YES NO
Now that you have read this article, can you:
1. Recognize the associations of pretibial myxedema with thyroid disease? YES NO
2. Recognize the lack of specific laboratory values for pretibial myxedema? YES NO
3. Describe the treatment modalities of pretibial myxedema? YES NO
What questions do you still have?___________________________________
How will you use what you have learned from this activity?________________
All tests must be received by 12/15/03.
References 1. Schwartz KM, Fatourechi V, Ahmed DD, et al. Dermopathy of Graves’ disease (pretibial myxedema): Long-term outcome. J Clin Endocrinol Metab 2002;87:438–46. 2. Georgala S, Katoulis AC, Georgala C, et al. Pretibial myxedema as the initial manifestation of Graves’ disease. J Eur Acad Dermatol Venereol 2002;16:380–3. 3. Omohundro C, Dijkstra JW, Camisa C, et al. Early onset pretibial myxedema in the absence of ophthalmopathy: A morphologic evolution. Cutis 1996;58:211–4. 4. Wu SL, Chang TC, Chang TJ, et al. Cloning and sequencing of complete thyrotropin receptor transcripts in pretibial fibroblast culture cells. J Endocrinol Invest 1996;19:365–70. 5. Cheung HS, Nicoloff JT, Kamiel MB, et al. Stimulation of fibroblast biosynthetic activity by serum of patients with pretibial myxedema. J Invest Dermatol 1978;71:12–7. 6. Peacey SR, Flemming L, Messenger A, et al. Is Graves’ dermopathy a generalized disorder? Thyroid 1996;6:41–5. 7. Wortsman J, Dietrich J, Traycoff RB, et al. Preradial myxedema in thyroid disease. Arch Dermatol 1981;117:635–8. 8. Somach SC, Helm TN, Lawlor KB, et al. Pretibial mucin. Histologic patterns and clinical correlation. Arch Dermatol 1993;129:1152–6. 9. Kriss JP. Pathogenesis and treatment of pretibial myxedema. Endocrinol Metab Clin North Am 1987;16:409–15. 10. Chang CC, Chang TC, Kao SC, et al. Pentoxifylline inhibits the proliferation and glycosaminoglycan synthesis of cultured fibroblasts derived from patients with Graves’ ophthalmopathy and pretibial myxedema. Acta Endocrinol 1993;129:322–7. 11. Antonelli A, Navarranne A, Palla R, et al. Pretibial myxedema and high-dose intravenous immunoglobulin treatment. Thyroid 1994;4:399–408. 12. Chang TC, Kao SC, Huang KM. Octreotide and Graves’ ophthalmopathy and pretibial myxedema. BMJ 1992;304:158.
_sm.jpg)
Post new comment